sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
¸ÉÑÛ²¡¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ¸ÉÑÛ²¡¶¯ÎïÄ£×Ó

ǰÑÔ

¸ÉÑÛ²¡£¬ÓÖÃû¸ÉÔïÐԽǽáĤ²¡£¬ÊÇÑÛ¿Æ×î³£¼ûµÄ¼²²¡Ö®Ò»£¬¿ÉÒýÆðÑÛ±íËðÉ˺ÍÊÓÁ¦Ä£ºýµÈ£¬¶øÓ°Ïìµ½»¼ÕßµÄÉúÑÄÖÊÁ¿ ¡£ÏÖÔÚ£¬´ó´ó¶¼¸ÉÑÛ²¡»¼Õß²¡Òò²»Ã÷£¬µ«½ÏÑÏÖØµÄ¸ÉÑÛ²¡¶àÓë×ÔÉíÃâÒßÏà¹Ø ¡£¶¯ÎïʵÑéÊÇÑо¿Æä·¢²¡»úÖÆµÄÖ÷ÒªÊֶΣ¬ÒÔÍùµÄ¸ÉÑÛ²¡Ä£×ÓÖ÷ÒªÓÐÕª³ýÀáÏÙ¡¢È¥³ýÑÛ±íµÄÉñ¾­Ö§Åä¡¢µ÷Àí¶¯ÎïÐÔ¼¤ËØÉøÍ¸µÈ ¡£ÓÉÓÚ½üÄêÀ´µÄÑо¿Ð§¹ûÏÔʾÃâÒ߸ıäÔÚ¸ÉÑ۵ķ¢²¡ÖÐÆðÖ÷Òª×÷Óã¬ÏÖÔÚ½¨ÉèµÄ¸ÉÑÛÄ£×Ó¶àΪÓÕµ¼ÑÛ±í»òÀáÏÙ±¬·¢Ñ×Ö¢·´Ó¦µÄ×ÔÉíÃâÒßÏà¹ØÄ£×Ó ¡£ÒÔÏÂÖ÷ÒªÏÈÈÝÒ»ÖÖ»ùÒòÇóýСÊóÄ£×Ó ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

´ó×ÚʵÑéЧ¹ûÏÔʾ¸ÉÑÛ²¡ÊÇÒ»ÖÖÑ×Ö¢ÐÔ×ÔÉíÃâÒßÐÔ¼²²¡£¬ÌåÏÖΪÑÛ±í×ÔÉíÃâÒßÐÔTϸ°ûµÄ½þÈó£¬ÀáÏÙ¹¦Ð§µ¥Î»µÄºã¾ÃÂýÐÔÑ×Ö¢£¬¿Éµ¼Ö½ÇĤÆÁÕϹ¦Ð§µÄËðʧ¡¢ÑÛ±íÉÏÆ¤Ï¸°ûµÄµòÍö¡¢±­×´Ï¸°ûµÄËðʧ¼°ÑÛ±íµÄÁÛ×´»¯Éú ¡£

MRL/lprСÊó£¬ÓÉÃÀ¹úJacksonʵÑéÊÒµÄMurphyºÍRothsÔÚ1978ÄêÅàÓýÀֳɣ¬ÓÉLG/J¡¢AKR/J¡¢C3H/D ¼°C57BL/6¼¸ÖÖ²î±ðƷϵСÊó¾­ÓÉһϵÁÐÖØ´óµÄÔÓ½»ÖÁµÚ12´úʱ±¬·¢£¬Æä·´×ª×ù×Ó²åÈëFas»ùÒòÄÚº¬×Ó£¬µ¼ÖÂFasת¼±í´ïÒì³£¶ø²»¿ÉÓÕµ¼µòÍö£¬´Ó¶øÊ¹ÁܰÍϸ°ûÔöֳʧ¿Ø£¬TÁܰÍϸ°ûÔöÉú ¡£

¡¾Ä£×ÓÌØµã¡¿£º

MRL/lprСÊóÀáÏÙÑ×Ö¢ÔÚÊóÁä1¸öÔÂʱ±¬·¢£¬MRL/£«Ð¡ÊóÀáÏÙÑ×ÐÔ½þÈ󱬷¢½ÏÍí£¬Ò²Ã»ÓÐMRL/lprСÊóÌåÏÖµÃÑÏÖØ£¬µ«ËüÔÚÊóÁä3¸öÔÂʱҲ»á±¬·¢ÀáÏÙÑ×Ö¢£¬Õâ¾ÍÅú×¢£¬lprµÄ±äÒìÖ»ÊǼӾçÁ˸ÉÑ۵ı¬·¢£¬¶ø²»ÊÇÆäÐγɵÄÔµ¹ÊÔ­ÓÉ ¡£MRL/lprСÊóȱÏÝÐÔÁܰÍϸ°ûµÄµòÍöÊÇÓɳ£È¾É«ÌåÒþÐÔ»ùÒòlprµÄ±äÒìÒýÆðµÄ£¬Ëüµ¼ÖÂÁ˳ýÀáÏÙÍâÈ«Éí±¬·¢Fas¿¹Ô­£¬Òò´Ë¿ÉÒԵóö½áÂÛ£¬lpr»ùÒòµÄ±äÒì²¢²»Êǵ¼ÖÂÀáÏÙ΢ÇéÐθıäµÄΨһÒòËØ ¡£lpr»ùÒòµÄ±äÒì²¢²»¿ÉÒýÆðÑÏÖØµÄ×ÔÉíÃâÒßÐԵIJ¡±ä£¬ÓÉÓÚÐÛÐÔC3H/lprСÊóºÍϵͳÐÔÁܰÍϸ°ûÔöÉúÐÔ¼²²¡(generalized lymphoproliferative disease)СÊóµÄÀáÏÙÖв¢Î´·¢Ã÷ÁܰÍϸ°û±äÒì ¡£ÕâЩ·¢Ã÷ËÆºõÖ§³ÖÕâÑùÒ»ÖÖ¼Ù˵£¬Fas¿¹Ô­ºÍFas¿¹Ìå²¢²»ÊÇÀáÏÙÃâÒßË𺦵ÄÒªº¦ÒòËØ ¡£ÕâÖÖÄ£×ÓµÄÃâÒß²¡Àí»úÖÆÊÇÆæÒìµÄ£¬Ö÷ÒªÊÇÀáÏÙ×éÖ¯ÖÐIL-4ÓëB7-2±¬·¢µÄTh2Ðͳ¬Ãô·´Ó¦ ¡£

¡¾Ä£×ÓȪԴ¡¿£º

ÃÀ¹úJacksonʵÑéÊÒ(http://www.?jax:.org/index.htrnl)ºÍÄϾ©´óѧģʽ¶¯ÎïÑо¿Ëù(http:// www.nrcmm.cn)¾ù¿ÉÌṩ ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

MRL+ºÍMRL/lprСÊó³£±»ÓÃ×öϵͳÐÔºì°ßÀÇ´¯µÄÑо¿£¬ÒàÓÐÑо¿·¢Ã÷MRl/£«ºÍMRL/lpСÊó¿ÉÉú³¤ÎªÀáÏÙÑס¢ÏÑÏÙÑס¢ÈùÏÙÑ×¼°ÉàÏÂÏÙÑ×£¬ÆäÀáÏÙÒÔCD4+?ÁܰÍϸ°û½þÈóΪÖ÷ÒªÌØÕ÷£¬´ÆÐÔÌåÏֵĸüΪÑÏÖØ ¡£MRL/£«ºÍMRL/lprСÊóÒ»Ö±ÊÇÍâÑó³£ÓõÄÍÙÒºÏÙºÍÀáÏÙËðÉ˵Ä×ÔÉíÃâÒßÐÔ¼²²¡Ä£×ÓÖ®Ò» ¡£

?

²Î¿¼ÎÄÏ×£º

1.ÇñÅàèª.?½ÇĤÐÂÉúѪ¹ÜµÄ¶¯ÎïÄ£×Ó£®ÍâÑóҽѧ£ºÑÛ¿ÆÑ§·Ö²á£¬2000, 24 (6):360-363

2.ºú¶«¶«£¬Íõ¼ÎÈÝ£¬ÑîÔÚ¸»£®¼¤¹âÑÛËðÉ˶¯ÎïУÐÍÑо¿Ï£Íû£®¾üÊÂҽѧ¿ÆÑ§ÔºÔº¿¯£¬2010,5:489-491

3.Äô°®ÇÛ£¬Ï¯Ã磬ϯÐË»ª£¬µÈ´¿´â°ÌÕ¶¾ÐÔ½ÇĤÑ×¢òÊóÄ£×ӵĽ¨Éè¼°ÅжϹú¼ÊÑÛ¿ÆÔÓÖ¾£¬2012,12(11): 2059-2061

4.ÐìÑÒ±äÓ¦ÐÔ½áĤÑ×¶¯ÎïÄ£×ÓÑÛ¿ÆÑо¿£¬2001, 19(2):181-183

5.κÈ𻪣¬ºÂÓÀÄÈ£¬ÕÔÉÙÕ꣮×ÔÉíÃâÒßÏà¹ØÐÔ¸ÉÑÛ¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÑÛ¿ÆÐÂÏ£Íû£¬2012, 32 (7):690-693

6.Calonge MC, Pastor JC, Herreras JM, el al. Pharmacologic modulation of vascular permeability in ocular allergy in?the rat.?Invest Ophthalmol Vis Sci, 1990, 31 (1): 176-180

7.Marquart ME.Animal models of bacterial keratitis.J Biomed Biotechnol,2011,2011:680642

8.Pavan-Langston D. Herpes simplex virus ocular infections:current concepts of acute, latent and reactivated disease. Trans Am Ophthalmol Soc, 1990,88:727-796

?

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ¸ÉÑÛ²¡¶¯ÎïÄ£×Ó
¸ÉÑÛ²¡¶¯ÎïÄ£×Ó

ǰÑÔ

¸ÉÑÛ²¡£¬ÓÖÃû¸ÉÔïÐԽǽáĤ²¡£¬ÊÇÑÛ¿Æ×î³£¼ûµÄ¼²²¡Ö®Ò»£¬¿ÉÒýÆðÑÛ±íËðÉ˺ÍÊÓÁ¦Ä£ºýµÈ£¬¶øÓ°Ïìµ½»¼ÕßµÄÉúÑÄÖÊÁ¿ ¡£ÏÖÔÚ£¬´ó´ó¶¼¸ÉÑÛ²¡»¼Õß²¡Òò²»Ã÷£¬µ«½ÏÑÏÖØµÄ¸ÉÑÛ²¡¶àÓë×ÔÉíÃâÒßÏà¹Ø ¡£¶¯ÎïʵÑéÊÇÑо¿Æä·¢²¡»úÖÆµÄÖ÷ÒªÊֶΣ¬ÒÔÍùµÄ¸ÉÑÛ²¡Ä£×ÓÖ÷ÒªÓÐÕª³ýÀáÏÙ¡¢È¥³ýÑÛ±íµÄÉñ¾­Ö§Åä¡¢µ÷Àí¶¯ÎïÐÔ¼¤ËØÉøÍ¸µÈ ¡£ÓÉÓÚ½üÄêÀ´µÄÑо¿Ð§¹ûÏÔʾÃâÒ߸ıäÔÚ¸ÉÑ۵ķ¢²¡ÖÐÆðÖ÷Òª×÷Óã¬ÏÖÔÚ½¨ÉèµÄ¸ÉÑÛÄ£×Ó¶àΪÓÕµ¼ÑÛ±í»òÀáÏÙ±¬·¢Ñ×Ö¢·´Ó¦µÄ×ÔÉíÃâÒßÏà¹ØÄ£×Ó ¡£ÒÔÏÂÖ÷ÒªÏÈÈÝÒ»ÖÖ»ùÒòÇóýСÊóÄ£×Ó ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

´ó×ÚʵÑéЧ¹ûÏÔʾ¸ÉÑÛ²¡ÊÇÒ»ÖÖÑ×Ö¢ÐÔ×ÔÉíÃâÒßÐÔ¼²²¡£¬ÌåÏÖΪÑÛ±í×ÔÉíÃâÒßÐÔTϸ°ûµÄ½þÈó£¬ÀáÏÙ¹¦Ð§µ¥Î»µÄºã¾ÃÂýÐÔÑ×Ö¢£¬¿Éµ¼Ö½ÇĤÆÁÕϹ¦Ð§µÄËðʧ¡¢ÑÛ±íÉÏÆ¤Ï¸°ûµÄµòÍö¡¢±­×´Ï¸°ûµÄËðʧ¼°ÑÛ±íµÄÁÛ×´»¯Éú ¡£

MRL/lprСÊó£¬ÓÉÃÀ¹úJacksonʵÑéÊÒµÄMurphyºÍRothsÔÚ1978ÄêÅàÓýÀֳɣ¬ÓÉLG/J¡¢AKR/J¡¢C3H/D ¼°C57BL/6¼¸ÖÖ²î±ðƷϵСÊó¾­ÓÉһϵÁÐÖØ´óµÄÔÓ½»ÖÁµÚ12´úʱ±¬·¢£¬Æä·´×ª×ù×Ó²åÈëFas»ùÒòÄÚº¬×Ó£¬µ¼ÖÂFasת¼±í´ïÒì³£¶ø²»¿ÉÓÕµ¼µòÍö£¬´Ó¶øÊ¹ÁܰÍϸ°ûÔöֳʧ¿Ø£¬TÁܰÍϸ°ûÔöÉú ¡£

¡¾Ä£×ÓÌØµã¡¿£º

MRL/lprСÊóÀáÏÙÑ×Ö¢ÔÚÊóÁä1¸öÔÂʱ±¬·¢£¬MRL/£«Ð¡ÊóÀáÏÙÑ×ÐÔ½þÈ󱬷¢½ÏÍí£¬Ò²Ã»ÓÐMRL/lprСÊóÌåÏÖµÃÑÏÖØ£¬µ«ËüÔÚÊóÁä3¸öÔÂʱҲ»á±¬·¢ÀáÏÙÑ×Ö¢£¬Õâ¾ÍÅú×¢£¬lprµÄ±äÒìÖ»ÊǼӾçÁ˸ÉÑ۵ı¬·¢£¬¶ø²»ÊÇÆäÐγɵÄÔµ¹ÊÔ­ÓÉ ¡£MRL/lprСÊóȱÏÝÐÔÁܰÍϸ°ûµÄµòÍöÊÇÓɳ£È¾É«ÌåÒþÐÔ»ùÒòlprµÄ±äÒìÒýÆðµÄ£¬Ëüµ¼ÖÂÁ˳ýÀáÏÙÍâÈ«Éí±¬·¢Fas¿¹Ô­£¬Òò´Ë¿ÉÒԵóö½áÂÛ£¬lpr»ùÒòµÄ±äÒì²¢²»Êǵ¼ÖÂÀáÏÙ΢ÇéÐθıäµÄΨһÒòËØ ¡£lpr»ùÒòµÄ±äÒì²¢²»¿ÉÒýÆðÑÏÖØµÄ×ÔÉíÃâÒßÐԵIJ¡±ä£¬ÓÉÓÚÐÛÐÔC3H/lprСÊóºÍϵͳÐÔÁܰÍϸ°ûÔöÉúÐÔ¼²²¡(generalized lymphoproliferative disease)СÊóµÄÀáÏÙÖв¢Î´·¢Ã÷ÁܰÍϸ°û±äÒì ¡£ÕâЩ·¢Ã÷ËÆºõÖ§³ÖÕâÑùÒ»ÖÖ¼Ù˵£¬Fas¿¹Ô­ºÍFas¿¹Ìå²¢²»ÊÇÀáÏÙÃâÒßË𺦵ÄÒªº¦ÒòËØ ¡£ÕâÖÖÄ£×ÓµÄÃâÒß²¡Àí»úÖÆÊÇÆæÒìµÄ£¬Ö÷ÒªÊÇÀáÏÙ×éÖ¯ÖÐIL-4ÓëB7-2±¬·¢µÄTh2Ðͳ¬Ãô·´Ó¦ ¡£

¡¾Ä£×ÓȪԴ¡¿£º

ÃÀ¹úJacksonʵÑéÊÒ(http://www.?jax:.org/index.htrnl)ºÍÄϾ©´óѧģʽ¶¯ÎïÑо¿Ëù(http:// www.nrcmm.cn)¾ù¿ÉÌṩ ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

MRL+ºÍMRL/lprСÊó³£±»ÓÃ×öϵͳÐÔºì°ßÀÇ´¯µÄÑо¿£¬ÒàÓÐÑо¿·¢Ã÷MRl/£«ºÍMRL/lpСÊó¿ÉÉú³¤ÎªÀáÏÙÑס¢ÏÑÏÙÑס¢ÈùÏÙÑ×¼°ÉàÏÂÏÙÑ×£¬ÆäÀáÏÙÒÔCD4+?ÁܰÍϸ°û½þÈóΪÖ÷ÒªÌØÕ÷£¬´ÆÐÔÌåÏֵĸüΪÑÏÖØ ¡£MRL/£«ºÍMRL/lprСÊóÒ»Ö±ÊÇÍâÑó³£ÓõÄÍÙÒºÏÙºÍÀáÏÙËðÉ˵Ä×ÔÉíÃâÒßÐÔ¼²²¡Ä£×ÓÖ®Ò» ¡£

?

²Î¿¼ÎÄÏ×£º

1.ÇñÅàèª.?½ÇĤÐÂÉúѪ¹ÜµÄ¶¯ÎïÄ£×Ó£®ÍâÑóҽѧ£ºÑÛ¿ÆÑ§·Ö²á£¬2000, 24 (6):360-363

2.ºú¶«¶«£¬Íõ¼ÎÈÝ£¬ÑîÔÚ¸»£®¼¤¹âÑÛËðÉ˶¯ÎïУÐÍÑо¿Ï£Íû£®¾üÊÂҽѧ¿ÆÑ§ÔºÔº¿¯£¬2010,5:489-491

3.Äô°®ÇÛ£¬Ï¯Ã磬ϯÐË»ª£¬µÈ´¿´â°ÌÕ¶¾ÐÔ½ÇĤÑ×¢òÊóÄ£×ӵĽ¨Éè¼°ÅжϹú¼ÊÑÛ¿ÆÔÓÖ¾£¬2012,12(11): 2059-2061

4.ÐìÑÒ±äÓ¦ÐÔ½áĤÑ×¶¯ÎïÄ£×ÓÑÛ¿ÆÑо¿£¬2001, 19(2):181-183

5.κÈ𻪣¬ºÂÓÀÄÈ£¬ÕÔÉÙÕ꣮×ÔÉíÃâÒßÏà¹ØÐÔ¸ÉÑÛ¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÑÛ¿ÆÐÂÏ£Íû£¬2012, 32 (7):690-693

6.Calonge MC, Pastor JC, Herreras JM, el al. Pharmacologic modulation of vascular permeability in ocular allergy in?the rat.?Invest Ophthalmol Vis Sci, 1990, 31 (1): 176-180

7.Marquart ME.Animal models of bacterial keratitis.J Biomed Biotechnol,2011,2011:680642

8.Pavan-Langston D. Herpes simplex virus ocular infections:current concepts of acute, latent and reactivated disease. Trans Am Ophthalmol Soc, 1990,88:727-796

?

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿